Drawing for Serial No. 88097949

USPTO serial 88097949

Serial No. 88097949

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
LOBO, DEBORAH E
Law office
TMEG LAW OFFICE 109 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with Serial No. 88097949?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Oleg A. Mestechkin

Oleg A. Mestechkin Mestechkin Law Group PC2218 Ocean AvenueBrooklyn, NY 11229United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment and prevention of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system; pharmaceutical preparations for the treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Homeopathic pharmaceuticals for use in the treatment of chemical imbalancesACTIVEOct 17, 2018
042Development of pharmaceutical preparations and medicinesACTIVEOct 17, 2018

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 15, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 15, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 15, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 5, 2020MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Aug 5, 2020ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jan 23, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 23, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 23, 2020CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 6, 2020DOCKASSIGNED TO EXAMINER—
Nov 4, 2019DOCKASSIGNED TO EXAMINER—
Oct 31, 2019SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Oct 31, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Oct 16, 2019IUAFUSE AMENDMENT FILED—
Oct 16, 2019EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Apr 16, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 19, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 19, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 30, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 11, 2019ALIEASSIGNED TO LIE—
Dec 14, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 14, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Dec 14, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 14, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 14, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 12, 2018DOCKASSIGNED TO EXAMINER—
Sep 11, 2018MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Sep 8, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 1, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance